\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ sonographic\\ murphy\\'s\\.\ \(0\)\
\-\ normal\\ lft\\'s\\.\ \(0\)\
\-\ the\\ clinician\\ and\\ the\\ patient\\ will\\ discuss\\ the\\ options\\,\\ though\\ continued\\ monitoring\\ is\\ a\\ likely\\ plan\\ given\\ the\\ patient\\'s\\ age\\.\ \(0\)\
\-\ 6mm\\ x\\ 12mm\\ x\\ 11mm\\ hypoechoic\\ filling\\ defect\\ in\\ the\\ posterior\\ gallbladder\\ wall\\ with\\ a\\ broad\\ based\\ stalk\\ and\\ no\\ evidence\\ of\\ abnormal\\ shadowing\\.\\ \\ normally\\ distended\\ gallbladder\\ with\\ no\\ evidence\\ of\\ wall\\ thickening\\ or\\ pericholecystic\\ fluid\\.\ \(0\)\
\-\ gallbladder\\ polyp\\,\\ histological\\ diagnosis\\ unknown\ \(0\)\
\-\ cholesterol\\ polyp\\,\\ adherent\\ stone\\ or\\ sludge\\,\\ adenomyomatosis\\,\\ carcinoma\\,\\ metastasis\\ \\(melanoma\\,\\ gi\\,\\ breast\\)\\,\\ ectopic\\ mucosa\\,\\ benign\\ tumor\\ \\â\\€\\“\\ adenoma\\,\\ papilloma\\,\\ lipoma\ \(0\)\
\-\ 86\\ yo\\ woman\\ with\\ intermittent\\,\\ vague\\ epigastric\\ pain\\ and\\ normal\\ liver\\ function\\ on\\ laboratory\\ analysis\\.\ \(1\)\
\-\ given\\ the\\ size\\ of\\ the\\ polyp\\ and\\ the\\ patient\\'s\\ demographic\\,\\ malignancy\\ is\\ the\\ diagnosis\\ of\\ exclusion\\,\\ though\\ no\\ concerning\\ findings\\ \\(other\\ than\\ size\\)\\ were\\ noted\\ on\\ the\\ ultrasound\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polyp\\:\\ 0\\.3180922981456782\ \(0\)\
\-\ gallbladder\\:\\ 0\\.2791454432516544\ \(0\)\
\-\ the\\:\\ 0\\.20778267638731324\ \(0\)\
\-\ though\\:\\ 0\\.18093762281383538\ \(0\)\
\-\ 11mm\\:\\ 0\\.14980419375605603\ \(0\)\
\-\ given\\:\\ 0\\.14326557304360904\ \(0\)\
\-\ size\\:\\ 0\\.14101659681472692\ \(0\)\
\-\ 12mm\\:\\ 0\\.13907418507911454\ \(0\)\
\-\ demographic\\:\\ 0\\.13907418507911454\ \(0\)\
\-\ adenomyomatosis\\:\\ 0\\.1310085559167032\ \(0\)\
\-\ lft\\:\\ 0\\.12857094872508074\ \(0\)\
\-\ wall\\:\\ 0\\.12669037667070454\ \(0\)\
\-\ adherent\\:\\ 0\\.1264208268015084\ \(0\)\
\-\ discuss\\:\\ 0\\.12194613171456707\ \(0\)\
\-\ exclusion\\:\\ 0\\.12194613171456707\ \(0\)\
\-\ stalk\\:\\ 0\\.12042400567660677\ \(0\)\
\-\ sludge\\:\\ 0\\.11835519763909709\ \(0\)\
\-\ evidence\\:\\ 0\\.11821187118411394\ \(0\)\
\-\ clinician\\:\\ 0\\.1177146077983545\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.11649716094258573\ \(0\)\
\-\ 6mm\\:\\ 0\\.11591759044747459\ \(0\)\
\-\ 86\\:\\ 0\\.11591759044747459\ \(0\)\
\-\ cholesterol\\:\\ 0\\.11535585574981326\ \(0\)\
\-\ histological\\:\\ 0\\.11481089178115665\ \(0\)\
\-\ murphy\\:\\ 0\\.11376746852390228\ \(0\)\
\-\ plan\\:\\ 0\\.11326730196972105\ \(0\)\
\-\ diagnosis\\:\\ 0\\.10796341516949694\ \(0\)\
\-\ epigastric\\:\\ 0\\.10705467574196989\ \(0\)\
\-\ monitoring\\:\\ 0\\.1038438026649796\ \(0\)\
\-\ vague\\:\\ 0\\.1018910333363717\ \(0\)\
\-\ patient\\:\\ 0\\.10160752078098945\ \(0\)\
\-\ no\\:\\ 0\\.10158840899865866\ \(0\)\
\-\ shadowing\\:\\ 0\\.1003689072984114\ \(0\)\
\-\ mucosa\\:\\ 0\\.1003689072984114\ \(0\)\
\-\ concerning\\:\\ 0\\.09988848648681271\ \(0\)\
\-\ melanoma\\:\\ 0\\.09724460662321581\ \(0\)\
\-\ analysis\\:\\ 0\\.09683892465598624\ \(0\)\
\-\ papilloma\\:\\ 0\\.09548608827550731\ \(0\)\
\-\ stone\\:\\ 0\\.09511728912139449\ \(0\)\
\-\ normally\\:\\ 0\\.09493564645617562\ \(0\)\
\-\ broad\\:\\ 0\\.09405359386068236\ \(0\)\
\-\ options\\:\\ 0\\.09388218473991781\ \(0\)\
\-\ sonographic\\:\\ 0\\.09371237014570691\ \(0\)\
\-\ ectopic\\:\\ 0\\.09209583343505427\ \(0\)\
\-\ lipoma\\:\\ 0\\.09032784594012679\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.08897500955964782\ \(0\)\
\-\ distended\\:\\ 0\\.08897500955964782\ \(0\)\
\-\ gi\\:\\ 0\\.08747375823778461\ \(0\)\
\-\ and\\:\\ 0\\.08607107630875817\ \(0\)\
\-\ continued\\:\\ 0\\.0853236363142123\ \(0\)\
\-\ intermittent\\:\\ 0\\.08511136721041389\ \(0\)\
\-\ normal\\:\\ 0\\.08503345136250678\ \(0\)\
\-\ function\\:\\ 0\\.08428614479941066\ \(0\)\
\-\ adenoma\\:\\ 0\\.0830199617647316\ \(0\)\
\-\ of\\:\\ 0\\.08151331540658475\ \(0\)\
\-\ filling\\:\\ 0\\.08064126052043968\ \(0\)\
\-\ unknown\\:\\ 0\\.07890888994452847\ \(0\)\
\-\ malignancy\\:\\ 0\\.07795751561465619\ \(0\)\
\-\ defect\\:\\ 0\\.07638696418619499\ \(0\)\
\-\ metastasis\\:\\ 0\\.07632165128204169\ \(0\)\
\-\ breast\\:\\ 0\\.07561822166414238\ \(0\)\
\-\ laboratory\\:\\ 0\\.07561822166414238\ \(0\)\
\-\ based\\:\\ 0\\.07543098989731194\ \(0\)\
\-\ or\\:\\ 0\\.07245189664669163\ \(0\)\
\-\ liver\\:\\ 0\\.07183562124457306\ \(0\)\
\-\ benign\\:\\ 0\\.07153220810077397\ \(0\)\
\-\ thickening\\:\\ 0\\.07084326078211713\ \(0\)\
\-\ will\\:\\ 0\\.0670226587078024\ \(0\)\
\-\ age\\:\\ 0\\.06537560532351204\ \(0\)\
\-\ yo\\:\\ 0\\.06505626883221852\ \(0\)\
\-\ negative\\:\\ 0\\.0644679071319109\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0642310464212153\ \(0\)\
\-\ on\\:\\ 0\\.0628997885075744\ \(0\)\
\-\ abnormal\\:\\ 0\\.06256159433811763\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06228753675529053\ \(0\)\
\-\ likely\\:\\ 0\\.06222718980037412\ \(0\)\
\-\ with\\:\\ 0\\.06117151469483748\ \(0\)\
\-\ fluid\\:\\ 0\\.060123987146495125\ \(0\)\
\-\ than\\:\\ 0\\.05902992602809465\ \(0\)\
\-\ is\\:\\ 0\\.057034951771989105\ \(0\)\
\-\ noted\\:\\ 0\\.055211060266160426\ \(0\)\
\-\ tumor\\:\\ 0\\.054467498285262976\ \(0\)\
\-\ woman\\:\\ 0\\.05423270485896419\ \(0\)\
\-\ other\\:\\ 0\\.05407783701825035\ \(0\)\
\-\ posterior\\:\\ 0\\.05384797118266685\ \(0\)\
\-\ were\\:\\ 0\\.05367745158769358\ \(0\)\
\-\ findings\\:\\ 0\\.051393715620316624\ \(0\)\
\-\ pain\\:\\ 0\\.03726254953642767\ \(0\)\
\-\ in\\:\\ 0\\.025904862125940287\ \(0\)\
